In canine B-cell lymphoma and specifically in cDLBCL, the mechanism might be similar, since PI3K/AKT/mTOR pathway is frequently deregulated [8,39]. The gene discussed is AKT1; the disease is B-cell non-Hodgkin lymphoma.